| Breakdown | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 315.39M | 307.89M | 297.66M | 259.78M | 214.40M |
| Gross Profit | 112.48M | 109.49M | 102.64M | 81.56M | 35.87M |
| EBITDA | 120.05M | 115.87M | 107.94M | 94.34M | 63.17M |
| Net Income | 56.57M | 54.09M | 50.67M | 38.79M | 21.71M |
Balance Sheet | |||||
| Total Assets | 334.39M | 312.64M | 332.52M | 326.37M | 272.94M |
| Cash, Cash Equivalents and Short-Term Investments | 56.54M | 86.15M | 111.09M | 136.19M | 99.36M |
| Total Debt | 43.04M | 59.76M | 90.51M | 118.09M | 80.94M |
| Total Liabilities | 121.39M | 132.77M | 173.53M | 193.72M | 143.25M |
| Stockholders Equity | 213.00M | 179.87M | 158.99M | 132.65M | 127.97M |
Cash Flow | |||||
| Free Cash Flow | 28.68M | 32.55M | 33.69M | 42.23M | 27.49M |
| Operating Cash Flow | 90.76M | 87.17M | 83.33M | 74.90M | 53.87M |
| Investing Cash Flow | -60.50M | -47.57M | -52.68M | -31.13M | -33.91M |
| Financing Cash Flow | -54.47M | -60.67M | -56.95M | -7.50M | -21.85M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £514.49M | 12.56 | 30.42% | 4.70% | 2.34% | 8.14% | |
72 Outperform | £489.75M | 7.10 | 27.48% | 3.65% | 5.78% | -6.80% | |
70 Neutral | £509.84M | ― | 22.71% | 5.91% | -4.70% | -2.21% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | £564.85M | 28.89 | 8.04% | 4.87% | -7.30% | -59.71% | |
61 Neutral | £487.27M | 5.91 | 13.04% | 3.18% | 6.55% | 18.44% | |
54 Neutral | £515.64M | 79.43 | 4.62% | 1.02% | 10.74% | 237.07% |